<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03746795</url>
  </required_header>
  <id_info>
    <org_study_id>EITspiro</org_study_id>
    <nct_id>NCT03746795</nct_id>
  </id_info>
  <brief_title>Spirometry Using Electrical Impedance Tomography</brief_title>
  <acronym>EIT</acronym>
  <official_title>Realization of Spirometry Measurement Using Electrical Impedance Tomography (EIT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Czech Technical University in Prague</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Czech Technical University in Prague</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of this study is to test spirometry measurements using EIT with a calibration
      using tidal volume obtained from the simultaneous standard spirometry measurement. Another
      goal is to compare, based on the calibration, the spirometry parameters obtained from
      separate measurements using EIT and the standard spirometry using a pneumotachograph.

      All spirometry measurements will be conducted in accordance with the latest available
      standards of the American Thoracic Society (ATS) and European Respiratory Society (ERS) from
      the year 2005, including their emendation from 2017.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adding the pneumotachograph and antibacterial filter to the respiratory system can lead to
      increased dead space, flow resistance, and change the respiratory pattern. All of these
      negative features and reduced patient co-operation affect the measured results and their
      interpretation. The aim of this study is to test spirometry measurement using EIT and
      evaluate such spirometry parameters as forced vital capacity (FVC), forced expiratory volume
      exhaled in the first second of a forced expiration (FEV1) and ratio of FEV1/FVC called
      Tiffeneau index (TI) based on recalculation using the calibration constant. The study will be
      conducted using Ergostik (Geratherm, Germany) spirometer and EIT system Pulmovista 500
      (Dräger, Germany).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 27, 2017</start_date>
  <completion_date type="Actual">March 8, 2019</completion_date>
  <primary_completion_date type="Actual">January 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>During the experiment, six measurements will be performed for each examined individual to calculate the spirometric parameters of FVC, FEV1 and Tiffenea's index (TI) FEV1/FVC. Spirometry measurements will be performed in a randomized order: two standard spirometric examinations, two spirometric examinations using EIT and two simultaneous measurements using both methods.
Each subject will undergo all six measurements.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FVC</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>forced vital capacity (L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FEV1</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>forced expiratory volume exhaled in the first second of a forced expiration (L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TI</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>ratio of FEV1/FVC called Tiffeneau index (-)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Standard spirometry</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard spirometry measurement with a pneumotachograph alone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EIT alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spirometric examinations realized using the EIT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Simultaneous standard spirometry and EIT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Simultaneous measurement by spirometer and EIT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spirometric examinations realized using the EIT</intervention_name>
    <description>Spirometric examinations will be realized using the EIT alone.</description>
    <arm_group_label>EIT alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Simultaneous measurement by spirometer and EIT</intervention_name>
    <description>Spirometric examinations will be realized using the simultaneous measurement by spirometer and EIT</description>
    <arm_group_label>Simultaneous standard spirometry and EIT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males and females &gt; 18 years old

          -  Signed informed consent has been obtained

        Exclusion Criteria:

          -  Pregnancy

          -  Cardiac pacemakers

          -  Electrically active implant

          -  Critical illness

          -  Intrathoracic metal implants

          -  Value of body mass index (BMI)&gt;50
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>28 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karel Roubík, prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Czech Technical University in Prague, FBMI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Biomedical Technology Faculty of Biomedical Engineering Czech Technical University in Prague</name>
      <address>
        <city>Kladno</city>
        <state>Czech Republic</state>
        <zip>272 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <reference>
    <citation>Ngo C, Leonhardt S, Zhang T, Lüken M, Misgeld B, Vollmer T, Tenbrock K, Lehmann S. Linearity of electrical impedance tomography during maximum effort breathing and forced expiration maneuvers. Physiol Meas. 2017 Jan;38(1):77-86. doi: 10.1088/1361-6579/38/1/77. Epub 2016 Dec 22.</citation>
    <PMID>28004642</PMID>
  </reference>
  <reference>
    <citation>Vogt B, Löhr S, Zhao Z, Falkenberg C, Ankermann T, Weiler N, Frerichs I. Regional lung function testing in children using electrical impedance tomography. Pediatr Pulmonol. 2018 Mar;53(3):293-301. doi: 10.1002/ppul.23912. Epub 2017 Nov 14.</citation>
    <PMID>29136345</PMID>
  </reference>
  <reference>
    <citation>Lehmann S, Leonhardt S, Ngo C, Bergmann L, Ayed I, Schrading S, Tenbrock K. Global and regional lung function in cystic fibrosis measured by electrical impedance tomography. Pediatr Pulmonol. 2016 Nov;51(11):1191-1199. doi: 10.1002/ppul.23444. Epub 2016 Apr 29.</citation>
    <PMID>27127915</PMID>
  </reference>
  <reference>
    <citation>Vogt B, Zhao Z, Zabel P, Weiler N, Frerichs I. Regional lung response to bronchodilator reversibility testing determined by electrical impedance tomography in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L8-L19. doi: 10.1152/ajplung.00463.2015. Epub 2016 May 17.</citation>
    <PMID>27190067</PMID>
  </reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 13, 2018</study_first_submitted>
  <study_first_submitted_qc>November 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2018</study_first_posted>
  <last_update_submitted>March 8, 2019</last_update_submitted>
  <last_update_submitted_qc>March 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>electrical impedance tomography</keyword>
  <keyword>spirometric examination</keyword>
  <keyword>bioimpedance</keyword>
  <keyword>FVC</keyword>
  <keyword>FEV1</keyword>
  <keyword>Tiffeneau index</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>EIT anonymous images and corresponding spirometry data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

